Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
Moreau, Philippe, Prof, Pylypenko, Halyna, MD, Grosicki, Sebastian, MD, Karamanesht, Ievgenii, MD, Leleu, Xavier, MD, Grishunina, Maria, MD, Rekhtman, Grigoriy, MD, Masliak, Zvenyslava, MD, Robak, Tadeusz, Prof, Shubina, Anna, MD, Arnulf, Bertrand, MD, Kropff, Martin, MD, Cavet, James, MBBS, Esseltine, Dixie-Lee, MD, Feng, Huaibao, PhD, Girgis, Suzette, PhD, van de Velde, Helgi, MD, Deraedt, William, MSc, Harousseau, Jean-Luc, Prof
Published in The lancet oncology (01.05.2011)
Published in The lancet oncology (01.05.2011)
Get full text
Journal Article
Persistent Overall Survival Benefit and No Increased Risk of Second Malignancies With Bortezomib-Melphalan-Prednisone Versus Melphalan-Prednisone in Patients With Previously Untreated Multiple Myeloma
San Miguel, Jesús F, Schlag, Rudolf, Khuageva, Nuriet K, Dimopoulos, Meletios A, Shpilberg, Ofer, Kropff, Martin, Spicka, Ivan, Petrucci, Maria Teresa, Palumbo, Antonio, Samoilova, Olga S, Dmoszynska, Anna, Abdulkadyrov, Kudrat M, Delforge, Michel, Jiang, Bin, Mateos, Maria-Victoria, Anderson, Kenneth C, Esseltine, Dixie-Lee, Liu, Kevin, Deraedt, William, Cakana, Andrew, van de Velde, Helgi, Richardson, Paul G
Published in Journal of clinical oncology (01.02.2013)
Published in Journal of clinical oncology (01.02.2013)
Get full text
Journal Article
Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma
ARNULF, Bertrand, PYLYPENKO, Halyna, GROSICKI, Sebastian, KARAMANESHT, Levgenii, LELEU, Xavier, DE VELDE, Helgi Van, FENG, Huaibao, CAKANA, Andrew, DERAEDT, William, MOREAU, Philippe
Published in Haematologica (Roma) (01.12.2012)
Published in Haematologica (Roma) (01.12.2012)
Get full text
Journal Article
VMP (Bortezomib, Melphalan, and Prednisone) Is Active and Well Tolerated in Newly Diagnosed Patients With Multiple Myeloma With Moderately Impaired Renal Function, and Results in Reversal of Renal Impairment: Cohort Analysis of the Phase III VISTA Study
Dimopoulos, Meletios A, Richardson, Paul G, Schlag, Rudolf, Khuageva, Nuriet K, Shpilberg, Ofer, Kastritis, Efstathios, Kropff, Martin, Petrucci, Maria T, Delforge, Michel, Alexeeva, Julia, Schots, Rik, Masszi, Tamás, Mateos, Maria-Victoria, Deraedt, William, Liu, Kevin, Cakana, Andrew, van de Velde, Helgi, San Miguel, Jesús F
Published in Journal of clinical oncology (20.12.2009)
Published in Journal of clinical oncology (20.12.2009)
Get full text
Journal Article
Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma
van de Velde, Helgi J.K, Liu, Xiangyang, Chen, Gang, Cakana, Andrew, Deraedt, William, Bayssas, Martine
Published in Haematologica (Roma) (01.10.2007)
Published in Haematologica (Roma) (01.10.2007)
Get full text
Journal Article
Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study
Moreau, Philippe, Pylypenko, Halyna, Grosicki, Sebastian, Karamanesht, Ievgenii, Leleu, Xavier, Rekhtman, Grigoriy, Masliak, Zvenyslava, Robak, Pawel, Esseltine, Dixie-Lee, Feng, Huaibao, Deraedt, William, van de Velde, Helgi, Arnulf, Bertrand
Published in Haematologica (Roma) (01.05.2015)
Published in Haematologica (Roma) (01.05.2015)
Get full text
Journal Article
The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapies
Crawford, Rebecca, Gries, Katharine S., Valluri, Satish, Fastenau, John, Morrison, Ross, Yeh, Tzu‐Min, Olyslager, Yunsi, Goldberg, Jenna D., Schecter, Jordan M., Jackson, Carolyn C., Deraedt, William, Doward, Lynda
Published in Cancer reports (01.11.2022)
Published in Cancer reports (01.11.2022)
Get full text
Journal Article
Ciltacabtagene Autoleucel for Patients With Triple‐class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE‐1 Patient Outcomes Versus Real‐world Clinical Practice
Delforge, Michel, Vekemans, Marie‐Christiane, Depaus, Julien, Meuleman, Nathalie, Van de Velde, Ann, Vande Broek, Isabelle, Vandervennet, Sophie, Van Hoorenbeeck, Sandra, Moorkens, Evelien, Strens, Danielle, Diels, Joris, Ghilotti, Francesca, Haefliger, Benjamin, Dalhuisen, Sander, Deraedt, William, Anguille, Sébastien
Published in HemaSphere (01.12.2022)
Published in HemaSphere (01.12.2022)
Get full text
Journal Article
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
Mateos, María-Victoria, Dimopoulos, Meletios A., Cavo, Michele, Suzuki, Kenshi, Jakubowiak, Andrzej, Knop, Stefan, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Kaplan, Polina, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre, Liberati, Anna M., Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Iosava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Chiu, Christopher, Wang, Jianping, Carson, Robin, Crist, Wendy, Deraedt, William, Nguyen, Huong, Qi, Ming, San-Miguel, Jesus
Published in The New England journal of medicine (08.02.2018)
Published in The New England journal of medicine (08.02.2018)
Get full text
Journal Article
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Palumbo, Antonio, Chanan-Khan, Asher, Weisel, Katja, Nooka, Ajay K., Masszi, Tamas, Beksac, Meral, Spicka, Ivan, Hungria, Vania, Munder, Markus, Mateos, Maria V., Mark, Tomer M., Qi, Ming, Schecter, Jordan, Amin, Himal, Qin, Xiang, Deraedt, William, Ahmadi, Tahamtan, Spencer, Andrew, Sonneveld, Pieter
Published in The New England journal of medicine (25.08.2016)
Published in The New England journal of medicine (25.08.2016)
Get full text
Journal Article
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up
Martin, Thomas, Usmani, Saad Z, Berdeja, Jesus G, Agha, Mounzer, Cohen, Adam D, Hari, Parameswaran, Avigan, David, Deol, Abhinav, Htut, Myo, Lesokhin, Alexander, Munshi, Nikhil C, O'Donnell, Elizabeth, Stewart, A Keith, Schecter, Jordan M, Goldberg, Jenna D, Jackson, Carolyn C, Yeh, Tzu-Min, Banerjee, Arnob, Allred, Alicia, Zudaire, Enrique, Deraedt, William, Olyslager, Yunsi, Zhou, Changwei, Pacaud, Lida, Madduri, Deepu, Jakubowiak, Andrzej, Lin, Yi, Jagannath, Sundar
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Palumbo, Antonio, Chanan-Khan, Asher, Weisel, Katja, Nooka, Ajay K, Masszi, Tamas, Beksac, Meral, Spicka, Ivan, Hungria, Vania, Munder, Markus, Mateos, Maria V, Mark, Tomer M, Qi, Ming, Schecter, Jordan, Amin, Himal, Qin, Xiang, Deraedt, William, Ahmadi, Tahamtan, Spencer, Andrew, Sonneveld, Pieter
Published in The New England journal of medicine (25.08.2016)
Published in The New England journal of medicine (25.08.2016)
Get full text
Journal Article
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
Berdeja, Jesus G, Madduri, Deepu, Usmani, Saad Z, Jakubowiak, Andrzej, Agha, Mounzer, Cohen, Adam D, Stewart, A Keith, Hari, Parameswaran, Htut, Myo, Lesokhin, Alexander, Deol, Abhinav, Munshi, Nikhil C, O'Donnell, Elizabeth, Avigan, David, Singh, Indrajeet, Zudaire, Enrique, Yeh, Tzu-Min, Allred, Alicia J, Olyslager, Yunsi, Banerjee, Arnob, Jackson, Carolyn C, Goldberg, Jenna D, Schecter, Jordan M, Deraedt, William, Zhuang, Sen Hong, Infante, Jeffrey, Geng, Dong, Wu, Xiaoling, Carrasco-Alfonso, Marlene J, Akram, Muhammad, Hossain, Farah, Rizvi, Syed, Fan, Frank, Lin, Yi, Martin, Thomas, Jagannath, Sundar
Published in The Lancet (British edition) (24.07.2021)
Published in The Lancet (British edition) (24.07.2021)
Get full text
Journal Article
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
Moreau, Philippe, Attal, Michel, Hulin, Cyrille, Arnulf, Bertrand, Belhadj, Karim, Benboubker, Lotfi, Béné, Marie C, Broijl, Annemiek, Caillon, Hélène, Caillot, Denis, Corre, Jill, Delforge, Michel, Dejoie, Thomas, Doyen, Chantal, Facon, Thierry, Sonntag, Cécile, Fontan, Jean, Garderet, Laurent, Jie, Kon-Siong, Karlin, Lionel, Kuhnowski, Frédérique, Lambert, Jérôme, Leleu, Xavier, Lenain, Pascal, Macro, Margaret, Mathiot, Claire, Orsini-Piocelle, Frédérique, Perrot, Aurore, Stoppa, Anne-Marie, van de Donk, Niels WCJ, Wuilleme, Soraya, Zweegman, Sonja, Kolb, Brigitte, Touzeau, Cyrille, Roussel, Murielle, Tiab, Mourad, Marolleau, Jean-Pierre, Meuleman, Nathalie, Vekemans, Marie-Christiane, Westerman, Matthijs, Klein, Saskia K, Levin, Mark-David, Fermand, Jean Paul, Escoffre-Barbe, Martine, Eveillard, Jean-Richard, Garidi, Reda, Ahmadi, Tahamtan, Zhuang, Sen, Chiu, Christopher, Pei, Lixia, de Boer, Carla, Smith, Elena, Deraedt, William, Kampfenkel, Tobias, Schecter, Jordan, Vermeulen, Jessica, Avet-Loiseau, Hervé, Sonneveld, Pieter
Published in The Lancet (British edition) (06.07.2019)
Published in The Lancet (British edition) (06.07.2019)
Get full text
Journal Article
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
Mateos, María-Victoria, Dimopoulos, Meletios A, Cavo, Michele, Suzuki, Kenshi, Jakubowiak, Andrzej, Knop, Stefan, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Kaplan, Polina, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre, Liberati, Anna M, Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Iosava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Chiu, Christopher, Wang, Jianping, Carson, Robin, Crist, Wendy, Deraedt, William, Nguyen, Huong, Qi, Ming, San-Miguel, Jesus
Published in The New England journal of medicine (08.02.2018)
Published in The New England journal of medicine (08.02.2018)
Get full text
Journal Article
Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents
Cohen, Adam D., Mateos, María-Victoria, Cohen, Yael C., Rodriguez-Otero, Paula, Paiva, Bruno, van de Donk, Niels W. C. J., Martin, Thomas, Suvannasankha, Attaya, De Braganca, Kevin C., Corsale, Christina, Schecter, Jordan M., Varsos, Helen, Deraedt, William, Wang, Liwei, Vogel, Martin, Roccia, Tito, Xu, Xiaoying, Mistry, Pankaj, Zudaire, Enrique, Akram, Muhammad, Nesheiwat, Tonia, Pacaud, Lida, Avivi, Irit, San-Miguel, Jesus
Published in Blood (19.01.2023)
Published in Blood (19.01.2023)
Get full text
Journal Article
Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma
Martin, Tom, Usmani, Saad Z., Schecter, Jordan M., Vogel, Martin, Jackson, Carolyn C., Deraedt, William, Tian, Hong, Yeh, Tzu-min, Banerjee, Arnob, Pacaud, Lida, Garrett, Ashraf, Haltner, Anja, Cameron, Chris, Van Sanden, Suzy, Diels, Joris, Valluri, Satish, Samjoo, Imtiaz A.
Published in Current medical research and opinion (03.10.2021)
Published in Current medical research and opinion (03.10.2021)
Get full text
Journal Article
Characteristics and Outcomes in Patients with Lenalidomide-Refractory Relapsed/Refractory Multiple Myeloma Treated with 1-3 Prior Lines of Therapy: Analysis of the Individual Patient-Level Data from Daratumumab Clinical Trials
Dhakal, Binod, Einsele, Hermann, Schecter, Jordan M, Roccia, Tito, Deraedt, William, Lendvai, Nikoletta, Slaughter, Ana, Lonardi, Carolina, Connors, Kaitlyn, Qi, Keqin, Londhe, Anil, Carson, Robin, Voelker, Jennifer, Cost, Patricia, Valluri, Satish, Florendo, Erika, Pacaud, Lida, Yong, Kwee
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Patient-Reported Outcomes in the Phase 3 CARTITUDE-4 Study of Ciltacabtagene Autoleucel Vs Standard of Care in Patients with Lenalidomide-Refractory Multiple Myeloma after 1-3 Lines of Therapy
Mina, Roberto, Mylin, Anne K, Yokoyama, Hisayuki, Magen, Hila, Alsdorf, Winfried, Minnema, Monique C, Shune, Leyla, Isufi, Iris, Harrison, Simon J., Shah, Urvi A, Schecter, Jordan M., Lendvai, Nikoletta, Gries, Katharine S, Katz, Eva G, Slaughter, Ana, Lonardi, Carolina, Gilbert, Jane, Li, Quanlin, Deraedt, William, Costa Filho, Octavio, Patel, Nitin, Karlin, Lionel, Weisel, Katja
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma
Martin, Tom, Usmani, Saad Z., Schecter, Jordan M., Roccia, Tito, Jackson, Carolyn C., Deraedt, William, Yeh, Tzu-min, Banerjee, Arnob, Pacaud, Lida, Garrett, Ashraf, Bartlett, Meaghan, Haltner, Anja, Van Sanden, Suzy, Diels, Joris, Valluri, Satish, Samjoo, Imtiaz A.
Published in Current medical research and opinion (02.01.2023)
Published in Current medical research and opinion (02.01.2023)
Get full text
Journal Article